The present disclosure provides compositions and formulations comprising botanicals and natural compounds for the promotion of healthy brain aging in adults and for prevention or inhibition of age associated neurodegenerative changes resulting in cognitive, memory and executive dysfunction including modulation of the age related predisposition to mild cognitive impairment, Alzheimer's disease, hormonal and other dementia related conditions. The present disclosure also provides methods of using the compositions and formulations in treating and preventing neurodegenerative changes resulting in cognitive, memory and executive dysfunction.

The present disclosure provides compositions and formulations comprising botanicals and natural compounds for the promotion of healthy brain aging in adults and for prevention or inhibition of age associated neurodegenerative changes resulting in cognitive, memory and executive dysfunction including modulation of the age related predisposition to mild cognitive impairment, Alzheimer's disease, hormonal and other dementia related conditions. The present disclosure also provides methods of using the compositions and formulations in treating and preventing neurodegenerative changes resulting in cognitive, memory and executive dysfunction.

The invention concerns a synthetic infant formula composition with a low content of medium-chain fatty acids in specific proportions and a relatively high content of unsaturated fatty acids, preferably polyunsaturated fatty acids. This composition is for infants, preferably preterm infants. This composition has been designed to promote the healthy establishment of cognitive function.

The invention concerns a synthetic infant formula composition with a low content of medium-chain fatty acids in specific proportions and a relatively high content of unsaturated fatty acids, preferably polyunsaturated fatty acids. This composition is for infants, preferably preterm infants. This composition has been designed to promote the healthy establishment of cognitive function.

Compositions and methods directed to a synergistic blend of amino acids for providing a health benefit to an animal are disclosed herein. The blend can include a synergistic combination of glycine, methionine, cysteine, and glutamine

Compositions and methods directed to a synergistic blend of amino acids for providing a health benefit to an animal are disclosed herein. The blend can include a synergistic combination of glycine, methionine, cysteine, and glutamine

Disclosed are nutritional compositions including human milk oligosaccharides that can be administered to individuals including preterm infants, infants, toddlers, and children for improving gastrointestinal function and tolerance, as well as the growth of beneficial bacteria. Additional suitable methods of using the nutritional compositions including the human milk oligosaccharides are also disclosed.

Disclosed are nutritional compositions including human milk oligosaccharides that can be administered to individuals including preterm infants, infants, toddlers, and children for improving gastrointestinal function and tolerance, as well as the growth of beneficial bacteria. Additional suitable methods of using the nutritional compositions including the human milk oligosaccharides are also disclosed.

A gelatin based edible energy composition including at least a protein based gelatin, a methylated xanthine, and a choline derivative. Other embodiments may be described and claimed including compositions with at least a flavorant and a sweetener.

A gelatin based edible energy composition including at least a protein based gelatin, a methylated xanthine, and a choline derivative. Other embodiments may be described and claimed including compositions with at least a flavorant and a sweetener.